Effective Disease Control Following Up to 10 Years of Treatment with Adalimumab in Patients with Long-Standing Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Final 10-Year Results of the DE019 Trial
Author(s):
Keystone, E.; Heijde, D. van der; Kavanaugh, A.; Kupper, H.; Liu, S.F.; Mozaffarian, N.
